Medical/Pharmaceuticals

Finalist teams for "2021 Asia Super Team:Future Land" are here

TAIPEI, Oct. 26, 2021 /PRNewswire/ -- Here comes "2021 Asia Super Team" again! It is the eighth consecutive year that the Taiwanese government holds the "Asia Super Team" competition. This year, the competition is centered around a new theme - Future Land - inviting enterprises fromJapan, Vietnam...

2021-10-26 12:44 3906

Antengene to Host its First R&D Days on November 16 and November 18, 2021

* Virtual Event (in English) on November 16 * On Site Event with Live Webcast (in Mandarin) on Nov 18 SHANGHAI and HONG KONG, Oct. 25, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, deve...

2021-10-25 20:00 4368

Hummingbird Bioscience to Collaborate with Merck on Clinical Trial of Anti-VISTA Antibody HMBD-002 in Combination with KEYTRUDA® (Pembrolizumab) for Treatment of Cancer

HOUSTON and SINGAPORE, Oct. 25, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to improve treatment outcomes, today announced it has entered into a clinical trial collaboration agreem...

2021-10-25 17:00 2052

Farrer Park Hospital Offers Transcatheter Aortic Valve Implantation (TAVI)

SINGAPORE, Oct. 25 , 2021 /PRNewswire/ -- Farrer Park Hospital ("FPH") offers TAVI as an alternative treatment option for those suffering from aortic valve stenosis who are elderly or for younger patients who are not suitable for open-heart surgery. In aortic valve stenosis, the aortic valve sit...

2021-10-25 13:09 2970

A Singapore-based HealthTech Startup Redefines Chronic Disease Care with Promising Clinic Acquisition

SINGAPORE, Oct. 25, 2021 /PRNewswire/ -- A HealthTech start-up, HeartVoice announced its acquisition of Integrated Wellness Clinic in Novena Specialist Center. The clinic has been offering Health Screening services for corporate clients since 2015, pioneering this field,having served over 600 cor...

2021-10-25 10:30 3429

NCCN Works with Polish Health Leaders to Improve Cancer Standardization, Coordination, and Outcomes

PLYMOUTH MEETING, Pa., Oct. 25, 2021 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—today announced the publication of new NCCN Guidelines® for Cervical Cancer: Poland Edition. This is the organization's most-recent co...

2021-10-25 09:13 3689

INOVIO Announces Collaboration with Colombia; Memorandum of Understanding Focuses on Protecting Against COVID-19 and Supporting Broader Health Preparedness Initiatives

Memorandum of Understanding builds on recent regulatory authorization from INVIMAto conduct INNOVATE Phase 3 trial for INO-4800, INOVIO's COVID-19 vaccine candidate,in Colombia Colombia authorization augments recent regulatory authorizations from Brazil, the Philippines and Mexico to commence it...

2021-10-21 20:00 4536

Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on October 28 at 9:30 CEST

STOCKHOLM, Oct. 21, 2021 /PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFOGunilla Andersson. To register for the presentation of ...

2021-10-21 16:28 2181

Antengene Enters into a Research Collaboration & License Option Agreement with LegoChem Biosciences for New Antibody-Drug Conjugate Candidates

SHANGHAI and HONG KONG, Oct. 21, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncol...

2021-10-21 16:00 4369

UNO Technologies announces collaboration with Aetos Pharma to further accelerate Malaysia's healthcare tech transformation

SINGAPORE, Oct. 20, 2021 /PRNewswire/ -- UNO Technologies, a rapidly growing Medical Technology ("med tech") firm based inSingapore, has recently announced its expansion into the Malaysian market. As part of its regional strategy, UNO will team up with Aetos Pharma, a burgeoning Malaysian pharmac...

2021-10-21 12:38 4624

IND Application for Phase III Clinical Study of Anti-HER2 Bispecific Antibody KN026 was Officially Accepted by CDE

SUZHOU, China, Oct. 21, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. (stock code: 1093.HK) jointly announced IND application for a phase III clinical study of recombinant humanized anti-HER2 bispecific antibody KN026 (KN026-306) was official...

2021-10-21 10:31 3605

Singapore-based Biosyngen receives 500 million yuan in investment

SINGAPORE, Oct. 21, 2021 /PRNewswire/ -- At the 12th Singapore-Guangdong Collaboration Council (SGCC) meeting held online onOctober 20, Singapore-based Biosyngen Pte. Ltd. ("Biosyngen") announced its partnership with wholly state-owned Chinese company Science City (Guangzhou) Investment Group Co....

2021-10-21 09:30 7617

EVERSANA and Intouch Group join forces, adding the premiere digital-first agency network to the market leader in next generation commercialization

CHICAGO and KANSAS CITY, Mo., Oct. 20, 2021 /PRNewswire/ -- EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, andIntouch Group®, a full-service global agency network serving the pharmaceutical industry, today announced that they signed an agreemen...

2021-10-20 22:34 4883

BioVaxys Files US Patent Application for Pan-Sarbecovirus Vaccine

VANCOUVER, BC, Oct. 20, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV), (FRA:5LB), (OTCQB:BVAXF) ("BioVaxys" or "Company"), announced today that it has filed with the United States Patent & Trademark Office ("USPTO") a provisional patent application for its haptenized viral antigen va...

2021-10-20 21:24 5643

Seoul Gangnam-gu kicks off 2021 Medical Tourism Brand Festa

SEOUL, South Korea, Oct. 20, 2021 /PRNewswire/ -- Gangnam-gu (the Mayor of Gangnam-gu, Jeong sungun) is holdiong the '2021 Gangnam Medical Festa' in Nonhyeon-ro and Sinsa-ro areas for the month of October with the theme of 'Gangnam connected to the world, Gangnam, a healthy medical city'.

2021-10-20 20:05 2440

Island Pharmaceuticals to discuss its potential dengue fever preventative at Pharma Meeting Brazil & Latam 2021

MELBOURNE, Australia, Oct. 20, 2021 /PRNewswire/ -- Australian mid-clinical stage antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA) is pleased to be attending Pharma Meeting Brazil & Latam 2021, this week and presenting to potential partners. Island's attendance at the co...

2021-10-20 18:00 3441

HistoIndex and Galecto to Collaborate on Galecto's Phase 2a MYLOX-1 Clinical Trial to Advance Myelofibrosis Assessment with AI-based Stain-free Digital Pathology

SINGAPORE, Oct. 20, 2021 /PRNewswire/ -- HistoIndex , a global leading artificial intelligence digital pathology (AI-DP) provider, has announced a collaboration with Galecto, Inc., a biotechnology company focused on the development of novel treatments for fibrosis an...

2021-10-20 18:00 2253

Xinhua Silk Road: 52nd Zhangshu National Traditional Chinese Materia Medica Trade Fair kicks off in E. China's Jiangxi

BEIJING, Oct. 20, 2021 /PRNewswire/ -- The 52nd Zhangshu National Traditional Chinese Materia MedicaTrade Fair opened in Zhangshu, a country-level city in eastChina's Jiangxi Province on Saturday.

2021-10-20 17:27 4277

A Hypercompact CRISPR Technology Developed by GenKOre is deemed a Potential Game Changer in Gene Therapy.

DAEJEON, South Korea, Oct. 20, 2021 /PRNewswire/ -- On September 2, 2021, a scientific paper from GenKOre on the new hypercompact CRISPR system called CRISPR/Cas12f-GE was published in an online issue of Nature Biotechnology (IF 54.9), one of the world's top-tier biotechnology journals.

2021-10-20 15:31 4246

Getinge Q3 Report 2021: "Strong order intake and our remediation measures completed in Germany"

GOTHENBURG, Sweden, Oct. 20, 2021 /PRNewswire/ -- "Organic order intake increased by more than 20% in the third quarter, with a strong performance in all business areas and regions," says Mattias Perjos, President & CEO at Getinge. "Our cash flow remains strong, meaning that we have strengthened ...

2021-10-20 15:19 4219